A detailed history of Harbor Capital Advisors, Inc. transactions in Innoviva, Inc. stock. As of the latest transaction made, Harbor Capital Advisors, Inc. holds 136,722 shares of INVA stock, worth $2.62 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
136,722
Previous 94,895 44.08%
Holding current value
$2.62 Million
Previous $1.56 Million 69.67%
% of portfolio
0.11%
Previous 0.12%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$16.33 - $20.04 $683,034 - $838,213
41,827 Added 44.08%
136,722 $2.64 Million
Q2 2024

Jul 09, 2024

BUY
$14.4 - $16.4 $1.09 Million - $1.24 Million
75,685 Added 393.99%
94,895 $1.56 Million
Q1 2024

May 13, 2024

BUY
$14.56 - $16.78 $279,697 - $322,343
19,210 New
19,210 $293,000

Others Institutions Holding INVA

About Innoviva, Inc.


  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.33B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Harbor Capital Advisors, Inc. Portfolio

Follow Harbor Capital Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbor Capital Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Harbor Capital Advisors, Inc. with notifications on news.